Literature DB >> 2841923

DNA topoisomerases and DNA repair.

C S Downes, R T Johnson.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2841923     DOI： 10.1002/bies.950080602

Source DB:  PubMed          Journal:  Bioessays        ISSN： 0265-9247            Impact factor:   4.345


× No keyword cloud information.
  11 in total

1.  Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis.

Authors:  C S Downes; A M Mullinger; R T Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 2.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  The effect of novobiocin on yeast topoisomerase type II.

Authors:  M J Pocklington; J R Jenkins; E Orr
Journal:  Mol Gen Genet       Date:  1990-01

4.  A DNA topoisomerase II-independent route for novobiocin-mediated resistance to DNA binding agents.

Authors:  P J Smith; S M Bell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.

Authors:  S R Musk; G G Steel
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

6.  The effects of inhibitors of topoisomerase II and quinacrine on ultraviolet-light-induced DNA incision in normal and xeroderma pigmentosum fibroblasts.

Authors:  H W Thielmann; O Popanda; L Edler
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

8.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

9.  Inhibition of radiation-induced neoplastic transformation by beta-lapachone.

Authors:  D A Boothman; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 12.779

10.  Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.

Authors:  J M Cunningham; G E Francis; M J Holland; K F Pirollo; E H Chang
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.